This is an application to renew the Infectious Diseases/Basic Microbial Pathogenesis Training Grant from Washington University. With the advent of generally available antibiotic therapy 40-50 years ago, many physicians and scientists predicted the end of infectious diseases as a major area of health concern. Subsequent events have proven this prediction wrong, and the past decades have seen the emergence of many newly identified infectious diseases, including Lyme Disease, erlichiosis, SARS, West Nile encephalitis, avian influenza, and HIV, as major health problems. The reemergence of old infectious diseases, such as malaria and bacterial infections, in new more virulent and more antibiotic resistant forms also has increased public attention on the health problems posed by infectious diseases. The threat of microbial bioterrorism has also come to the forefront. It is rare that a week goes by without some troubling headline concerning new infectious disease outbreaks. Thus, far from gradual disappearance as a health concern, infectious diseases have emerged in the past decade as being of even greater importance to the health concerns of the nation than previously. The emerging antibiotic resistance of current pathogens, the discovery of new disease agents, and the specter of bioterrorism have made clear the necessity of increased fundamental scientific investigation into all aspects of infectious diseases. The purpose of the Washington University Training Program in Infectious Diseases/Basic Microbial Pathogenesis is to help fulfill this need by recruiting promising young investigators to this field and training them in outstanding research programs with preeminent investigators who collaborate across multiple disciplines (or who function in interdisciplinary teams) to perform infectious disease research. Our Training Program, which has had NIH support for the past 25 years, integrates faculty from four departments: Medicine, Pediatrics, Molecular Microbiology and Pathology & Immunology. The program provides training to M.D., Ph.D., and M.D./Ph.D. postdoctoral fellows, and to Ph.D. and M.D./Ph.D. students, in disciplines related to pathogenesis and host defense in Infectious Diseases. The laboratories of the program preceptors use tools of molecular biology, biochemistry, genetics, genomics, immunology, and cell biology. The clinical research component includes epidemiology, biostatistics, clinical trials, outcomes research, health economics, health behavior research and informatics tools and methods to train patient-oriented and translational researchers. Thus, the program trains young investigators to be able to answer the important questions of microbial pathogenesis, from studies of basic biology through application to the bedside. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007172-29
Application #
7491009
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Mcsweegan, Edward
Project Start
1980-09-15
Project End
2010-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
29
Fiscal Year
2008
Total Cost
$489,947
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Dunlap, Micah D; Howard, Nicole; Das, Shibali et al. (2018) A novel role for C-C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis. Mucosal Immunol 11:1727-1742
Wilke, Georgia; Ravindran, Soumya; Funkhouser-Jones, Lisa et al. (2018) Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro. mSphere 3:
Caine, Elizabeth A; Jagger, Brett W; Diamond, Michael S (2018) Animal Models of Zika Virus Infection during Pregnancy. Viruses 10:
Ligon, Marianne M; Mysorekar, Indira U (2018) Trans-mission control in the urinary tract: Local cytokine regulation of monocyte proliferation to combat infection. J Leukoc Biol 103:5-7
Mathews, Emily S; Odom John, Audrey R (2018) Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination. F1000Res 7:
Yokoyama, Christine C; Baldridge, Megan T; Leung, Daisy W et al. (2018) LysMD3 is a type II membrane protein without an in vivo role in the response to a range of pathogens. J Biol Chem 293:6022-6038
Olson, Patrick D; McLellan, Lisa K; Hreha, Teri N et al. (2018) Androgen exposure potentiates formation of intratubular communities and renal abscesses by Escherichia coli. Kidney Int 94:502-513
Wegscheid, Michelle L; Anastasaki, Corina; Gutmann, David H (2018) Human stem cell modeling in neurofibromatosis type 1 (NF1). Exp Neurol 299:270-280
Istvan, Eva S; Mallari, Jeremy P; Corey, Victoria C et al. (2017) Esterase mutation is a mechanism of resistance to antimalarial compounds. Nat Commun 8:14240
Spillman, Natalie J; Beck, Josh R; Ganesan, Suresh M et al. (2017) The chaperonin TRiC forms an oligomeric complex in the malaria parasite cytosol. Cell Microbiol 19:

Showing the most recent 10 out of 219 publications